“Seven years after their publication, the Medical Devices and In Vitro Diagnostic Medical Devices Regulations continue to hamper access to lifesaving and life-sustaining medical technologies as they are plagued by inefficient and unpredictable processes, skyrocketing cost of compliance, insufficient support for innovation and a lack of accountable governance.”
Strong words from industry association MedTech Europe in a statement responding to news that Ursula von der Leyen has been re-elected to serve a second term at the head of...